Dr. Jorge J. Nieva
Claim this profileUSC / Norris Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
27 drugs studied
About Jorge J. Nieva
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Associated with the USC Norris Comprehensive Cancer Center, a part of the Keck School of Medicine at USC.
- Serves as a medical oncologist, specializing in cancer treatment and research.
- Engages in a multidisciplinary team approach to enhance patient care, prevention, research, and education in cancer treatment.
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage IV
2Non-Small Cell Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Jorge J. Nieva is currently running
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting1 award Phase 119 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jorge J. Nieva
Clinical Trial Related5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jorge J. Nieva has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- Nivolumab
- Biospecimen Collection
- Berzosertib
Breakdown of trials Jorge J. Nieva has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jorge J. Nieva specialize in?
Jorge J. Nieva focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Jorge J. Nieva currently recruiting for clinical trials?
Yes, Jorge J. Nieva is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jorge J. Nieva has studied deeply?
Yes, Jorge J. Nieva has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Jorge J. Nieva?
Apply for one of the trials that Jorge J. Nieva is conducting.
What is the office address of Jorge J. Nieva?
The office of Jorge J. Nieva is located at: USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC / Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.